Alpha2* Nicotinic Acetylcholine Receptors as a Therapeutic Target for Memory EnhancementWednesday, 28 September 2011 at 16:30 Add to Calendar ▼2011-09-28 16:30:002011-09-28 17:30:00Europe/London Alpha2* Nicotinic Acetylcholine Receptors as a Therapeutic Target for Memory EnhancementIon Channel Targets in San FranciscoSan FranciscoSELECTBIOenquiries@selectbiosciences.com The alpha2* nicotinic acetylcholine receptor (nAChR), the most sparsely expressed nAChR subtype in the brain, is uniquely expressed in GABAergic interneurons in the hippocampus. This receptor subtype has emerged as a potential new therapeutic target for memory enhancement. |